ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025
Towards a 'people and nature' paradigm for biodiversity and infectious disease.
Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Local Knowledge of Land Use Effects on Human-Rodent Interfaces in Lassa-Endemic Nigeria.EcoHealth · 2026Article
- The socio-economic shield limits Lassa virus spillover in urban West Africa.Epidemiology and infection · 2026Article
- Applying one health approaches to addressing disease risks in wildlife trade: Insights from a special issue.One health (Amsterdam, Netherlands) · 2026Article
- Non-monotonic effects and spatial spillovers of urban green space on chronic infectious disease dynamics in China.Scientific reports · 2026Article
- Land use gradients drive spatial variation in Lassa fever host communities in the Eastern Province of Sierra Leone.The Journal of animal ecology · 2026Article
- Scaling Lassa Virus Dynamics within Anthropogenic Ecosystems (SCAPES) Study Protocol: a mixed-methods observational cohort study of humans, rodents, and landscapes in Nigeria.Wellcome open research · 2026Article
- Nanomaterial-Enhanced Electrochemical Sensors for Clinical Monitoring of Acyclovir: Integration Into Molecular Diagnostics.Journal of clinical laboratory analysis · 2025Review
- Weak compliance with Nigeria's wildlife trade ban imposed to curb mpox spillovers.Proceedings. Biological sciences · 2025Article
- Article
- Mosses in Urban Environments as Passive Biofilters and Organisms Impacted by Asbestos-Contaminated Habitats.International journal of environmental research and public health · 2025Review
- How should we bend the curve of biodiversity loss to build a just and sustainable future?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025Article
- Protocol to produce a systematic Arenavirus and Hantavirus host-pathogen database: Project ArHa.Wellcome open research · 2025Article
- Interconnected environmental ethics: navigating human, animal, and planetary health in the climate crisis.Global bioethics = Problemi di bioetica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Zoonotic and vector-borne infectious diseases are among the most direct human health consequences of biodiversity change. The COVID-19 pandemic increased health policymakers' attention on the links between ecological degradation and disease, and sparked discussions around nature-based interventions to mitigate zoonotic emergence and epidemics. Yet, although disease ecology provides an increasingly granular knowledge of wildlife disease in changing ecosystems, we still have a poor understanding of the net consequences for human disease. Here, we argue that a renewed focus on wildlife-borne diseases as complex socio-ecological systems-a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.